About & Contact 2017-10-18T08:17:23+00:00

CONTACTUS

First Name

Email

Last Name

Phone Number


Message




stroke-7_1-2-0_map-marker_50_0_002e7c_none

Stirling House,
Denny End Road,
Waterbeach,
Cambridge
CB25 9QE

+44 (0)1223 792 222

 


First Name

Email

Last Name

Phone Number


Message




stroke-7_1-2-0_map-marker_50_0_002e7c_none

Stirling House,
Denny End Road,
Waterbeach,
Cambridge
CB25 9QE

+44 (0)1223 792 222

 


ABOUTTHETEAM

Tim Bullock
Chairman

is co-founder of New Wave Ventures LLP, funding a broad spectrum of technology companies aiming to disrupt high value global markets. In addition to CSI, Tim chairs 2 biotech companies – Discuva and Bactevo – and serves as a director of a further 4 companies. Tim spent 14 years as a Managing Director at Lloyds Bank Group and has been involved in a number of successful mergers, acquisitions and restructurings.

 
 

Dr. Hugh Malkin
CEO

has a PhD in Chemistry and broad academic and business experience. Working in drug discovery research before moving into business development and senior management positions, Hugh has in-depth knowledge of Pharmaceutical and Life-Science research along with product development from concept to market, and business growth.
Hugh has successfully identified market needs and setup and managed companies to deliver products and solutions for these.

Nick Hastings
CTO

trained as an electronics/software engineer, has extensive experience gained over 30 years developing a wide range of products through to successful commercial launch.
Nick Spent 20 years at TTP, 10 years as a member of the senior management team, responsible for 40+ engineers.
Nick has been directly involved in over 200 innovative technology and product developments – including consumer, industrial, medical, automotive and aerospace.

Tim Bullock
Chairman

is co-founder of New Wave Ventures LLP, funding a broad spectrum of technology companies aiming to disrupt high value global markets. In addition to CSI, Tim chairs 2 biotech companies – Discuva and Bactevo – and serves as a director of a further 4 companies. Tim spent 14 years as a Managing Director at Lloyds Bank Group and has been involved in a number of successful mergers, acquisitions and restructurings.

 
 

Dr. Hugh Malkin
CEO

has a PhD in Chemistry and broad academic and business experience. Working in drug discovery research before moving into business development and senior management positions, Hugh has in-depth knowledge of Pharmaceutical and Life-Science research along with product development from concept to market, and business growth.
Hugh has successfully identified market needs and setup and managed companies to deliver products and solutions for these.

Nick Hastings
CTO

trained as an electronics/software engineer, has extensive experience gained over 30 years developing a wide range of products through to successful commercial launch.
Nick Spent 20 years at TTP, 10 years as a member of the senior management team, responsible for 40+ engineers.
Nick has been directly involved in over 200 innovative technology and product developments – including consumer, industrial, medical, automotive and aerospace.

Nick Williams
non-exec CFO

last 12 years as a finance leader with private equity backed, high growth, international business. Currently CFO of Jac Travel Group, £350m B2B travel services business. He was previously Group FD of Masternaut, Europe’s leading commercial vehicle tracking business.

Dr. Ian George
non-exec CSO

has a background in tech, commercialisation and early stage healthcare companies. Co-founded Enigma Diagnostics & led business development. Also worked as a consultant at TTP and at the Defence Science Tech. Lab, responsible for the formation of several spin-out companies.

Clive Hopewell
non-exec director

A specialist in corporate finance work and heads the capital markets group for law firm, Charles Russell Speechlys. Clive headed the Middle East practice in Bahrain and opened an office in Doha. Clive specialises in international fundraisings and mergers and acquisitions, both public and private.

Clive spent some time in the Equity Markets Group of the London Stock Exchange and his securities practice involves acting for institutions and issuers in respect of listings in London and elsewhere. Clive is well known in the industry and is author of the legal chapter in the latest London Stock Exchange “Guide to AIM”.

Dr. Omar Kamal
non-exec director

has a PhD in Management (Finance & Banking) and 20 plus years experience within financial services domain. Has co-led a major business group with a global span. Prior to that, acted as CIO of a Middle East bank and also an advisory ‘Partner’ with Ernst & Young. Omar has served on the board (including Chairmanship) of more than 10 companies including a FTSE 250 company, and is currently serving as an Independent Board member of the Arab Bank, and Tharisa Plc, a dual listed (London & Johannesburg) mining company.

Omar has leveraged his experience into high growth companies within Fintech, Regtech, Scientific Innovation, and E-commerce, some of which are amongst UK’s fastest growing “late- stage growth” businesses.

Nick Williams
non-exec CFO

last 12 years as a finance leader with private equity backed, high growth, international business. Currently CFO of Jac Travel Group, £350m B2B travel services business. He was previously Group FD of Masternaut, Europe’s leading commercial vehicle tracking business.

Dr. Ian George
non-exec CSO

has a background in tech, commercialisation and early stage healthcare companies. Co-founded Enigma Diagnostics & led business development. Also worked as a consultant at TTP and at the Defence Science Tech. Lab, responsible for the formation of several spin-out companies.

Clive Hopewell
non-exec director

A specialist in corporate finance work and heads the capital markets group for law firm, Charles Russell Speechlys. Clive headed the Middle East practice in Bahrain and opened an office in Doha. Clive specialises in international fundraisings and mergers and acquisitions, both public and private.

Clive spent some time in the Equity Markets Group of the London Stock Exchange and his securities practice involves acting for institutions and issuers in respect of listings in London and elsewhere. Clive is well known in the industry and is author of the legal chapter in the latest London Stock Exchange “Guide to AIM”.

Dr. Omar Kamal
non-exec director

has a PhD in Management (Finance & Banking) and 20 plus years experience within financial services domain. Has co-led a major business group with a global span. Prior to that, acted as CIO of a Middle East bank and also an advisory ‘Partner’ with Ernst & Young. Omar has served on the board (including Chairmanship) of more than 10 companies including a FTSE 250 company, and is currently serving as an Independent Board member of the Arab Bank, and Tharisa Plc, a dual listed (London & Johannesburg) mining company.

Omar has leveraged his experience into high growth companies within Fintech, Regtech, Scientific Innovation, and E-commerce, some of which are amongst UK’s fastest growing “late- stage growth” businesses.

PASTPRESENTFUTURE